A retrospective study assessing C-reactive protein to albumin ratio (CAR) before and after treatment with biological agents in patients with psoriasis
Latest Information Update: 27 Oct 2020
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Biomarker; Pharmacodynamics
- 27 Oct 2020 New trial record
- 31 Aug 2020 Results published in the Croatian Medical Journal